PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,138 | -25.5% | 4,235,000 | 0.0% | 0.37% | -24.6% |
| Q2 2023 | $14,950 | +14.2% | 4,235,000 | 0.0% | 0.49% | +21.1% |
| Q1 2023 | $13,086 | -27.0% | 4,235,000 | 0.0% | 0.40% | -34.5% |
| Q4 2022 | $17,914 | -99.8% | 4,235,000 | 0.0% | 0.61% | +100.0% |
| Q3 2022 | $10,037,000 | -16.8% | 4,235,000 | 0.0% | 0.31% | -41.4% |
| Q2 2022 | $12,070,000 | +4.8% | 4,235,000 | +5.9% | 0.52% | +25.7% |
| Q1 2022 | $11,520,000 | +84.9% | 4,000,000 | +95.1% | 0.42% | +94.9% |
| Q4 2021 | $6,232,000 | -74.0% | 2,050,000 | -40.1% | 0.21% | -71.0% |
| Q3 2021 | $24,009,000 | -4.0% | 3,425,000 | +25.7% | 0.74% | -12.3% |
| Q2 2021 | $25,016,000 | +0.7% | 2,725,000 | +6.7% | 0.84% | -1.1% |
| Q1 2021 | $24,835,000 | -5.3% | 2,555,000 | 0.0% | 0.85% | -7.4% |
| Q4 2020 | $26,214,000 | -49.2% | 2,555,000 | -50.0% | 0.92% | -32.4% |
| Q3 2020 | $51,560,000 | +106.0% | 5,110,000 | +112.9% | 1.36% | -5.0% |
| Q2 2020 | $25,032,000 | +52.1% | 2,400,000 | +23.1% | 1.43% | +45.7% |
| Q1 2020 | $16,458,000 | -37.8% | 1,950,000 | +50.0% | 0.98% | -21.7% |
| Q4 2018 | $26,455,000 | -23.1% | 1,300,000 | +73.3% | 1.26% | -14.7% |
| Q3 2018 | $34,388,000 | +42.2% | 750,000 | +15.4% | 1.47% | +50.1% |
| Q1 2017 | $24,180,000 | – | 650,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |